AAAAAA

   
Results: 1-11 |
Results: 11
T-CELL RECEPTOR PEPTIDE VACCINATION IN RHEUMATOID-ARTHRITIS - A PLACEBO-CONTROLLED TRIAL USING A COMBINATION OF V(BETA)3, V(BETA)14, AND V(BETA)17 PEPTIDES
Authors: MORELAND LW MORGAN EE ADAMSON TC FRONEK Z CALABRESE LH CASH JM MARKENSON JA MATSUMOTO AK BATHON J MATTESON EL URAMOTO KM WEYAND CM KOOPMAN WJ HECK LW STRAND V DIVELEY JP CARLO DJ NARDO CJ RICHIERI SP BROSTOFF SW
Citation: Lw. Moreland et al., T-CELL RECEPTOR PEPTIDE VACCINATION IN RHEUMATOID-ARTHRITIS - A PLACEBO-CONTROLLED TRIAL USING A COMBINATION OF V(BETA)3, V(BETA)14, AND V(BETA)17 PEPTIDES, Arthritis and rheumatism, 41(11), 1998, pp. 1919-1929
T-CELL RECEPTOR PEPTIDES AS IMMUNOTHERAPY FOR AUTOIMMUNE-DISEASE
Authors: GOLD DP SHROEDER K GOLDING A BROSTOFF SW WILSON DB
Citation: Dp. Gold et al., T-CELL RECEPTOR PEPTIDES AS IMMUNOTHERAPY FOR AUTOIMMUNE-DISEASE, Critical reviews in immunology, 17(5-6), 1997, pp. 507-510
RESULTS OF A PHASE-I CLINICAL-TRIAL OF A T-CELL RECEPTOR PEPTIDE VACCINE IN PATIENTS WITH MULTIPLE-SCLEROSIS .1. ANALYSIS OF T-CELL RECEPTOR UTILIZATION IN CSF CELL-POPULATIONS
Authors: WILSON DB GOLDING AB SMITH RA DAFASHY T NELSON J SMITH L CARLO DJ BROSTOFF SW GOLD DP
Citation: Db. Wilson et al., RESULTS OF A PHASE-I CLINICAL-TRIAL OF A T-CELL RECEPTOR PEPTIDE VACCINE IN PATIENTS WITH MULTIPLE-SCLEROSIS .1. ANALYSIS OF T-CELL RECEPTOR UTILIZATION IN CSF CELL-POPULATIONS, Journal of neuroimmunology, 76(1-2), 1997, pp. 15-28
RESULTS OF A PHASE-I CLINICAL-TRIAL OF A T-CELL RECEPTOR VACCINE IN PATIENTS WITH MULTIPLE-SCLEROSIS .2. COMPARATIVE-ANALYSIS OF TCR UTILIZATION IN CSF T-CELL POPULATIONS BEFORE AND AFTER VACCINATION WITH A TCRV-BETA-6 CDR2 PEPTIDE
Authors: GOLD DP SMITH RA GOLDING AB MORGAN EE DAFASHY T NELSON J SMITH L DIVELEY J LAXER JA RICHIERI SP CARLO DJ BROSTOFF SW WILSON DB
Citation: Dp. Gold et al., RESULTS OF A PHASE-I CLINICAL-TRIAL OF A T-CELL RECEPTOR VACCINE IN PATIENTS WITH MULTIPLE-SCLEROSIS .2. COMPARATIVE-ANALYSIS OF TCR UTILIZATION IN CSF T-CELL POPULATIONS BEFORE AND AFTER VACCINATION WITH A TCRV-BETA-6 CDR2 PEPTIDE, Journal of neuroimmunology, 76(1-2), 1997, pp. 29-38
PERSISTENCE OF T-CELL CLONES IN PSORIATIC LESIONS
Authors: CHANG JCC SMITH LR FRONING KJ KURLAND HH SCHWABE BJ BLUMEYER KK KARASEK MA WILKINSON DI FARBER EM CARLO DJ BROSTOFF SW
Citation: Jcc. Chang et al., PERSISTENCE OF T-CELL CLONES IN PSORIATIC LESIONS, Archives of dermatology, 133(6), 1997, pp. 703-708
V-BETA-17 T-CELL RECEPTOR PEPTIDE VACCINATION IN RHEUMATOID-ARTHRITIS- RESULTS OF PHASE-I DOSE-ESCALATION STUDY
Authors: MORELAND LW HECK LW KOOPMAN WJ SAWAY PA ADAMSON TC FRONEK Z OCONNOR RD MORGAN EE DIVELEY JP RICHIERI SP CARLO DJ BROSTOFF SW
Citation: Lw. Moreland et al., V-BETA-17 T-CELL RECEPTOR PEPTIDE VACCINATION IN RHEUMATOID-ARTHRITIS- RESULTS OF PHASE-I DOSE-ESCALATION STUDY, Journal of rheumatology, 23(8), 1996, pp. 1353-1362
RESULTS OF A PHASE-I CLINICAL-TRIAL OF A T-CELL RECEPTOR VACCINE IN PATIENTS WITH MULTIPLE-SCLEROSIS
Authors: WILSON DB SMITH RA RICHIERI SP CARLO DJ BROSTOFF SW MORGAN EE GOLD DP
Citation: Db. Wilson et al., RESULTS OF A PHASE-I CLINICAL-TRIAL OF A T-CELL RECEPTOR VACCINE IN PATIENTS WITH MULTIPLE-SCLEROSIS, Neurology, 46(2), 1996, pp. 52002-52002
INSULIN-SECRETORY-GRANULE SPECIFIC T-CELL CLONES IN HUMAN IDDM
Authors: CHANG JCC LINARELLI LG LAXER JA FRONING KJ CARALLI LL BROSTOFF SW CARLO DJ
Citation: Jcc. Chang et al., INSULIN-SECRETORY-GRANULE SPECIFIC T-CELL CLONES IN HUMAN IDDM, Journal of autoimmunity, 8(2), 1995, pp. 221-234
NUCLEOTIDE-SEQUENCE OF THE LEWIS RAT GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR
Authors: SMITH LR LUNDEEN KA DIVELY JP CARLO DJ BROSTOFF SW
Citation: Lr. Smith et al., NUCLEOTIDE-SEQUENCE OF THE LEWIS RAT GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR, Immunogenetics, 39(1), 1994, pp. 80-80
CD8-CELLS IN PSORIATIC LESIONS PREFERENTIALLY USE T-CELL RECEPTOR V(BETA)3 AND( T)OR V(BETA)13.1 GENES/
Authors: CHANG JCC SMITH LR FRONING KJ SCHWABE BJ LAXER JA CARALLI LL KURLAND HH KARASEK MA WILKINSON DI CARLO DJ BROSTOFF SW
Citation: Jcc. Chang et al., CD8-CELLS IN PSORIATIC LESIONS PREFERENTIALLY USE T-CELL RECEPTOR V(BETA)3 AND( T)OR V(BETA)13.1 GENES/, Proceedings of the National Academy of Sciences of the United Statesof America, 91(20), 1994, pp. 9282-9286
V-BETA-17 T-CELL RECEPTOR PEPTIDE VACCINE - RESULTS OF A PHASE-I DOSE-FINDING STUDY IN PATIENTS WITH RHEUMATOID-ARTHRITIS
Authors: MORELAND LW HECK LW KOOPMAN WJ SAWAY PA ADAMSON TC FRONEK Z OCONNOR RD MORGAN EE BROSTOFF SW
Citation: Lw. Moreland et al., V-BETA-17 T-CELL RECEPTOR PEPTIDE VACCINE - RESULTS OF A PHASE-I DOSE-FINDING STUDY IN PATIENTS WITH RHEUMATOID-ARTHRITIS, Clinical research, 42(2), 1994, pp. 10000312-10000312
Risultati: 1-11 |